Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss gene found on chromosome 3q26.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Follicle Stimulating Hormone is important for fertility.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

People with alopecia areata are more likely to have other immune-related conditions.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Acute wounds heal well, but chronic wounds struggle due to ongoing inflammation and poor tissue repair.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Recognizing new allergens can help reduce contact dermatitis cases.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

New treatments offer hope for better managing hidradenitis suppurativa.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

New cytokine-targeted therapies show promise for treating alopecia areata.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Early balding linked to higher heart disease risk.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Type 2 diabetes may increase the risk of severe hair loss in African American women.